PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Ferucarbotran→

Ferucarbotran PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
Not available
Molecular formula
Not available
Molecular weight
Not available
Drug class
Superparamagnetic iron-oxide nanoparticle MRI contrast agentliver-specific reticuloendothelial contrast medium
Mechanism of action
Carboxydextran-coated superparamagnetic iron oxide nanoparticles are phagocytosed by Kupffer cells in the hepatic reticuloendothelial system. Their strong T2 and T2* relaxivity reduces signal intensity in normal liver parenchyma, increasing contrast between normal liver and lesions with reduced Kupffer-cell uptake.
Indications / reported uses
  • Contrast enhancement for magnetic resonance imaging of focal liver lesions, particularly to improve lesion detection and characterisation in the liver, under product authorisation.

Sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC2727962/ · https://pubmed.ncbi.nlm.nih.gov/23256052/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC4611768/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Ferucarbotran PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ferucarbotran Permitted Daily Exposure (PDE) report (the Ferucarbotran PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ferucarbotran Occupational Exposure Limit (OEL) report (the Ferucarbotran OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.